• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp (TSX:PRN)

9.510 -0.310 (-3.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp

< Previous 1 2 3 4 Next >
News headline image
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Today 6:30 EDT
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
May 14, 2026
Company to explore the potential of integrating TULSA-PRO with PSMA PET molecular imaging technologies to enhance ablation planning and monitoring 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Strong First Quarter 2026 Financial Results
May 07, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
April 16, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 01, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
March 27, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Upcoming Meeting Dates - March 23, 2026
March 23, 2026
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - The following is a list of Upcoming Meeting Dates announced this week... 
Via Newsfile
News headline image
CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 13, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 09, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
February 12, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
February 12, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Upcoming Investor Events
January 27, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health
February 05, 2026
Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditions 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®
January 15, 2026
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Surpasses 2025 TULSA-PRO® Installed Base Goal
January 12, 2026
Company’s year-end TULSA-PRO installed base stood at 78 systems; qualified sales pipeline grew to 97 new systems 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case
January 06, 2026
Profound Medical marks major milestone as the hospital launches its state-of-the-art iMRI suite to expand access to advanced prostate care 
From Profound Medical Corp.
Via GlobeNewswire
InvestorNewsBreaks – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering
December 31, 2025
Via Investor Brand Network
News headline image
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Corp. Announces Upsize of Private Placement
December 24, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025
Financing included participation by healthcare-dedicated investors alongside existing shareholders 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
December 19, 2025
Financing included participation by healthcare-dedicated investors alongside existing shareholders 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Reports Strong Third Quarter 2025 Financial Results
November 13, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
November 12, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
December 04, 2025
– CAPTAIN is the first randomized controlled trial ever comparing a new technology to the standard of care of robotic radical prostatectomy to successfully recruit to target – 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
November 11, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
November 28, 2025
New BPH module and clinical data reinforce the TULSA Procedure™’s versatility in prostate disease, superior patient benefits, and potential for mainstream adoption 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
November 10, 2025
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
November 18, 2025
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy 
From Profound Medical Corp.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap